πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 179 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10464983

Variants of adrenomedullin and calcitonin gene-related peptide and methods of use

The Board of Regents of the University of Oklahoma Β· Granted Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10398668

Glutamate treatment of cardiovascular disorders

The Board of Regents of the University of Oklahoma Β· Granted Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10392642

High molecular weight heparosan polymers and methods of production and use thereof

The Board of Regents of the University of Oklahoma Β· Granted Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10258613

Compositions for treating retinal degeneration and methods of production and use thereof

The Board of Regents of the University of Oklahoma Β· Granted Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10226523

Clostridium difficile vaccine and methods of use

The Board of Regents of the University of Oklahoma Β· Granted Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10206904

Licofelone derivatives and methods of use

The Board of Regents of the University of Oklahoma Β· Granted Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10174077

Method of inhibiting activity of cell surface fibroblast activation protein alpha

The Board of Regents of the University of Oklahoma Β· Granted Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10155789

Substrates and inhibitors of prolyl oligopeptidase and methods of use thereof

The Board of Regents of the University of Oklahoma Β· Granted Tue Dec 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10073109

Phages of biomarker capture and methods of use

The Board of Regents of the University of Oklahoma Β· Granted Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9987241

Enzyme conjugate and prodrug cancer therapy

The Board of Regents of the University of Oklahoma Β· Granted Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9969803

Monoclonal antibodies that inhibit the Wnt signaling pathway and methods of production and

The Board of Regents of the University of Oklahoma Β· Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9957305

Anti-C. difficile toxin antibodies and associated methods

The Board of Regents of the University of Oklahoma Β· Granted Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9950037

Enhancing progenitor cell numbers

The Board of Regents of the University of Oklahoma Β· Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9925209

Heparosan-polypeptide and heparosan-polynucleotide drug conjugates and methods of making a

The Board of Regents of the University of Oklahoma Β· Granted Tue Mar 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9902690

Ethoxylated surfactants

The Board of Regents of the University of Oklahoma Β· Granted Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9885072

High molecular weight heparosan polymers and methods of production of use thereof

The Board of Regents of the University of Oklahoma Β· Granted Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9862748

Peptide compounds and methods of production and use thereof

The Board of Regents of the University of Oklahoma Β· Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9839690

Singlet oxygen-labile linkers and methods of production and use thereof

The Board of Regents of the University of Oklahoma Β· Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9744235

Treatment of cardiovascular disorders with targeted nanoparticles

The Board of Regents of the University of Oklahoma Β· Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9688722

Substrates and inhibitors of prolyl oligopeptidase and methods of use

The Board of Regents of the University of Oklahoma Β· Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9687559

Heparosan polymers and methods of making and using same for the enhancement of therapeutic

The Board of Regents of the University of Oklahoma Β· Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9675662

Compositions for inhibition of RNA polymerase I and methods of production and use thereof

The Board of Regents of the University of Oklahoma Β· Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9663585

Anti-DCLK1 monoclonal antibodies and methods of production and use thereof

The Board of Regents of the University of Oklahoma Β· Granted Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9629914

Heparosan-based biomaterials and coatings and methods of production and use thereof

The Board of Regents of the University of Oklahoma Β· Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted